Suvvari Praneeth, Mishra Seema, Bhatnagar Sushma, Garg Rakesh, Bharati Sachidanand Jee, Gupta Nishkarsh, Kumar Vinod, Khan M A
Department of Onco-Anaesthesia & Palliative Medicine, Dr BRA-Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
Turk J Anaesthesiol Reanim. 2020 Jun;48(3):215-222. doi: 10.5152/TJAR.2019.45087. Epub 2019 Oct 4.
Radiation therapy is indicated in many solid tumours in children. Absolute immobility is required to precisely position children for optimal delivery of radiation energy to the target tissues, improve success rate and reduce the damage to nearby normal tissues. Intranasal (IN) administration of drugs is well tolerated, effective and fast acting. The primary aim of the present study was to evaluate the effectiveness of IN ketamine and dexmedetomidine for providing sedation in children before shifting to the radiotherapy suite. The secondary objective was to assess the requirement of propofol dosage in these patients.
A total of 243 children aged between 1 and 5 years scheduled to undergo external beam radiotherapy were randomised to receive 5 mg kg ketamine (group K, n=80), 2.5 μg kg dexmedetomidine (group D, n=85) or 0.5 ml of saline (group S, n=78) in each nostril. After 45 min, sedation score was measured according to the modified Ramsay score (MRS) at the time of shifting for radiation. Time to awakening and time to discharge after the procedure were also noted.
A significantly higher proportion of children in group D (84.7%) achieved an MRS score ≥3 as compared to group K (36.2%) and group S (3.84%). The total propofol dose (mg kg) required was significantly less in group D (p<0.01). The patients in group D required more time to awakening, but this difference was not clinically significant.
The present study demonstrated that IN dexmedetomidine is superior to IN ketamine to provide procedural sedation for radiotherapy in children.
放射治疗适用于许多儿童实体瘤。为了将儿童精确地定位,以便将辐射能量最佳地传递到目标组织、提高成功率并减少对附近正常组织的损伤,需要绝对的静止不动。经鼻给药耐受性良好、有效且起效快。本研究的主要目的是评估鼻内给予氯胺酮和右美托咪定在儿童转移至放疗室之前提供镇静作用的有效性。次要目的是评估这些患者丙泊酚剂量的需求。
总共243名年龄在1至5岁之间计划接受体外放射治疗的儿童被随机分组,每组鼻孔接受5mg/kg氯胺酮(K组,n = 80)、2.5μg/kg右美托咪定(D组,n = 85)或0.5ml生理盐水(S组,n = 78)。45分钟后,在转移至放疗时根据改良的Ramsay评分(MRS)测量镇静评分。还记录了术后苏醒时间和出院时间。
与K组(36.2%)和S组(3.84%)相比,D组中达到MRS评分≥3的儿童比例显著更高(84.7%)。D组所需的丙泊酚总剂量(mg/kg)显著更少(p<0.01)。D组患者苏醒所需时间更长,但这种差异无临床意义。
本研究表明,鼻内给予右美托咪定在为儿童放疗提供术中镇静方面优于鼻内给予氯胺酮。